Serpentide Inc. is a biotechnology company dedicated to revolutionizing peptide therapeutics for metabolic diseases. Our proprietary SHIELD (Sustained Half-life, Stable Release, Scalable Production) technology platform enables the development of ultra-long-lasting GLP-1 receptor agonist drugs, designed to improve patient outcomes in obesity and diabetes. Through innovative molecular design and strategic partnerships, such as our collaboration with Novo Nordisk, we aim to deliver next-generation therapies that transform lives.
Contact Detail: info@serpentide.com

Serpentide

Org chart

Teams

Offices

Serpentide

Org chart

Teams

Offices

Related companies